IVF SCHEDULE 13G/A: SEC filing
Alumni Capital LP
Filed with the SEC on · accession 0001213900-26-121000
IVF filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Alumni Capital LP filed an amended Schedule 13G reporting deemed beneficial ownership of 132,393 shares (9.99%) of INVO Fertility, Inc. common stock under an Any Market Purchase Agreement dated July 24, 2026. The stock moved -7.7% by the first close after the filing.
Summary of the filing
Alumni Capital LP filed an amended Schedule 13G reporting deemed beneficial ownership of 132,393 shares (9.99%) of INVO Fertility, Inc. common stock under an Any Market Purchase Agreement dated July 24, 2026. The fund currently owns no shares and disclaims beneficial ownership beyond its pecuniary interest.
Key details
How IVF stock reacted
Close before
$2.60
Nov 13, 2026
First close after
-7.69%
$2.40
5 trading days
—
Since filing
-14.95%
$2.21
✦ Ask GOAX AI about this filing — what it means for IVF, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IVF?
Click hereFrequently asked questions
What did IVF file with the SEC on Nov 16, 2026?
IVF filed a SCHEDULE 13G/A (SEC filing). Alumni Capital LP filed an amended Schedule 13G reporting deemed beneficial ownership of 132,393 shares (9.99%) of INVO Fertility, Inc. common stock under an Any Market Purchase Agreement dated July 24, 2026. The fund currently owns no shares and disclaims beneficial ownership beyond its pecuniary interest.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did IVF stock react to this filing?
IVF closed at $2.60 before the filing and $2.40 on Nov 16, 2026 (-7.69%).
Other IVF SEC filings
- 10-Q · SEC filingNov 16, 2026
- 8-K · SEC filingNov 16, 2026
- 8-K · Stock splitNov 4, 2026
- SCHEDULE 13G/A · SEC filingOct 9, 2026
- 8-K · Secondary offeringAug 28, 2026
- 8-K · SEC filingAug 17, 2026
- 10-Q · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 424B3 · Secondary offeringAug 7, 2026
- 8-K · Material agreementJul 24, 2026
Get alerts when IVF files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days